BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25385326)

  • 1. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria.
    Buckingham SC; Ramos TN; Barnum SR
    Epilepsia; 2014 Dec; 55(12):e139-42. PubMed ID: 25385326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
    Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
    Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility to pentylenetetrazol following survival of cerebral malaria in mice.
    Grauncke AC; Souza TL; Ribeiro LR; Brant F; Machado FS; Oliveira MS
    Epilepsia; 2016 Jul; 57(7):e140-5. PubMed ID: 27247141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.
    Ramos TN; Darley MM; Weckbach S; Stahel PF; Tomlinson S; Barnum SR
    J Biol Chem; 2012 Jul; 287(29):24734-8. PubMed ID: 22689574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
    Lackner P; Hametner C; Beer R; Burger C; Broessner G; Helbok R; Speth C; Schmutzhard E
    Malar J; 2008 Oct; 7():207. PubMed ID: 18847493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement components in the susceptibility to Plasmodium berghei infection among inbred strains of mice.
    Williams AI; Rosen FS; Hoff R
    Ann Trop Med Parasitol; 1975 Jun; 69(2):179-85. PubMed ID: 1098586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1A (ABCB1)-deficient CF-1 mutant mice are susceptible to cerebral malaria induced by Plasmodium berghei ANKA.
    de Lagerie SB; Fernandez C; German-Fattal M; Gantier JC; Gimenez F; Farinotti R
    J Parasitol; 2008 Oct; 94(5):1139-42. PubMed ID: 18973419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
    Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
    Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of experimental cerebral malaria is independent of IL-23 and IL-17.
    Ishida H; Matsuzaki-Moriya C; Imai T; Yanagisawa K; Nojima Y; Suzue K; Hirai M; Iwakura Y; Yoshimura A; Hamano S; Shimokawa C; Hisaeda H
    Biochem Biophys Res Commun; 2010 Nov; 402(4):790-5. PubMed ID: 21036146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
    Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
    J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent infection with Heligmosomoides polygyrus modulates murine host response against Plasmodium berghei ANKA infection.
    Tetsutani K; Ishiwata K; Torii M; Hamano S; Hisaeda H; Himeno K
    Am J Trop Med Hyg; 2008 Dec; 79(6):819-22. PubMed ID: 19052285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.
    Patel SN; Berghout J; Lovegrove FE; Ayi K; Conroy A; Serghides L; Min-oo G; Gowda DC; Sarma JV; Rittirsch D; Ward PA; Liles WC; Gros P; Kain KC
    J Exp Med; 2008 May; 205(5):1133-43. PubMed ID: 18426986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of
    Yi H; Jiang W; Yang F; Li F; Li Y; Zhu W; Li Q; Fakhar SH; Cao Y; Luo L; Zhang W; He Y
    Front Immunol; 2021; 12():719189. PubMed ID: 34456927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
    Reverchon F; Mortaud S; Sivoyon M; Maillet I; Laugeray A; Palomo J; Montécot C; Herzine A; Meme S; Meme W; Erard F; Ryffel B; Menuet A; Quesniaux VFJ
    PLoS Pathog; 2017 Apr; 13(4):e1006322. PubMed ID: 28448579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
    Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
    Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.
    Amani V; Boubou MI; Pied S; Marussig M; Walliker D; Mazier D; Rénia L
    Infect Immun; 1998 Sep; 66(9):4093-9. PubMed ID: 9712753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
    Nie CQ; Bernard NJ; Schofield L; Hansen DS
    Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.
    Ramos TN; Darley MM; Hu X; Billker O; Rayner JC; Ahras M; Wohler JE; Barnum SR
    J Immunol; 2011 Jun; 186(12):6657-60. PubMed ID: 21572031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.